HistologiX was formed in 2005 to provide quality Histology and Immunohistochemistry (IHC) Services and multi-site studies for the Pharmaceutical and Biotechnology industry. It was also our aim to provide human and animal tissue based solutions in support of regulatory preclinical programmes, clinical trials in addition to Biomarker development projects.

Initial GLP accreditation was obtained in November 2005 and retained by inspection in 2007 and retained until recent inspections in 2016. HistologiX is also licensed by the Human Tissue Authority (HTA) to source and store human tissue and has ethical approval to undertake antibody screening in human tissues and boasts customers in the UK, Europe, Scandanavia, Israel, South Africa, USA and Canada.

Histologix has taken the positive step through strategic agreements with external partners to bring to our clients services that include the sourcing of high quality normal and diseased human tissues, Toxicology, Pharmacology/PK, Tumour cell lines/xenograft efficacy studies, Biosimilar studies, clinical and veterinary trials. Our ability to support your drug programmes is now greatly enhanced by bringing together these service providers with niche areas of expertise to provide strong scientific solutions to your development issues.

Histologix continues to work with a range of clients that include some of the top pharmaceutical companies worldwide as well as small and medium but highly innovative biotechnology companies.


Antibodies intended for therapeutic clinical use must undergo screening in human tissue as part of any regulatory preclinical safety assessment.

Find out more

News & resources